» Articles » PMID: 37784151

MRI-based Inter- and Intrafraction Motion Analysis of the Pancreatic Tail and Spleen As Preparation for Adaptive MRI-guided Radiotherapy in Neuroblastoma

Overview
Journal Radiat Oncol
Publisher Biomed Central
Specialties Oncology
Radiology
Date 2023 Oct 2
PMID 37784151
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In pediatric radiotherapy treatment planning of abdominal tumors, dose constraints to the pancreatic tail/spleen are applied to reduce late toxicity. In this study, an analysis of inter- and intrafraction motion of the pancreatic tail/spleen is performed to estimate the potential benefits of online MRI-guided radiotherapy (MRgRT).

Materials And Methods: Ten randomly selected neuroblastoma patients (median age: 3.4 years), irradiated with intensity-modulated arc therapy at our department (prescription dose: 21.6/1.8 Gy), were retrospectively evaluated for inter- and intrafraction motion of the pancreatic tail/spleen. Three follow-up MRIs (T2- and T1-weighted ± gadolinium) were rigidly registered to a planning CT (pCT), on the vertebrae around the target volume. The pancreatic tail/spleen were delineated on all MRIs and pCT. Interfraction motion was defined as a center of gravity change between pCT and T2-weighted images in left-right (LR), anterior-posterior (AP) and cranial-caudal (CC) direction. For intrafraction motion analysis, organ position on T1-weighted ± gadolinium was compared to T2-weighted. The clinical radiation plan was used to estimate the dose received by the pancreatic tail/spleen for each position.

Results: The median (IQR) interfraction motion was minimal in LR/AP, and largest in CC direction; pancreatic tail 2.5 mm (8.9), and spleen 0.9 mm (3.9). Intrafraction motion was smaller, but showed a similar motion pattern (pancreatic tail, CC: 0.4 mm (1.6); spleen, CC: 0.9 mm (2.8)). The differences of Dmean associated with inter- and intrafraction motions ranged from - 3.5 to 5.8 Gy for the pancreatic tail and - 1.2 to 3.0 Gy for the spleen. In 6 out of 10 patients, movements of the pancreatic tail and spleen were highlighted as potentially clinically significant because of ≥ 1 Gy dose constraint violation.

Conclusion: Inter- and intrafraction organ motion results into unexpected constrain violations in 60% of a randomly selected neuroblastoma cohort, supporting further prospective exploration of MRgRT.

Citing Articles

Modeling of artificial intelligence-based respiratory motion prediction in MRI-guided radiotherapy: a review.

Zhang X, Yan D, Xiao H, Zhong R Radiat Oncol. 2024; 19(1):140.

PMID: 39380013 PMC: 11463122. DOI: 10.1186/s13014-024-02532-4.

References
1.
Taylor A, Winter D, Pritchard-Jones K, Stiller C, Frobisher C, Lancashire E . Second primary neoplasms in survivors of Wilms' tumour--a population-based cohort study from the British Childhood Cancer Survivor Study. Int J Cancer. 2008; 122(9):2085-93. DOI: 10.1002/ijc.23333. View

2.
van Dijk I, Oldenburger F, Cardous-Ubbink M, Geenen M, Heinen R, de Kraker J . Evaluation of late adverse events in long-term wilms' tumor survivors. Int J Radiat Oncol Biol Phys. 2010; 78(2):370-8. DOI: 10.1016/j.ijrobp.2009.08.016. View

3.
Vatanen A, Sarkola T, Ojala T, Turanlahti M, Jahnukainen T, Saarinen-Pihkala U . Radiotherapy-related arterial intima thickening and plaque formation in childhood cancer survivors detected with very-high resolution ultrasound during young adulthood. Pediatr Blood Cancer. 2015; 62(11):2000-6. DOI: 10.1002/pbc.25616. View

4.
Madenci A, Fisher S, Diller L, Goldsby R, Leisenring W, Oeffinger K . Intestinal Obstruction in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2015; 33(26):2893-900. PMC: 4554750. DOI: 10.1200/JCO.2015.61.5070. View

5.
Weil B, Madenci A, Liu Q, Howell R, Gibson T, Yasui Y . Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2018; 36(16):1571-1578. PMC: 5978467. DOI: 10.1200/JCO.2017.76.1643. View